Cargando…
Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases
[Image: see text] Janus kinases (JAKs) are enzymes involved in signaling pathways that affect hematopoiesis and immune cell functions. JAK1, JAK2, and JAK3 play different roles in numerous diseases of the immune system and have also been considered as potential targets for cancer therapy. In the pre...
Autores principales: | Sanachai, Kamonpan, Mahalapbutr, Panupong, Choowongkomon, Kiattawee, Poo-arporn, Rungtiva P., Wolschann, Peter, Rungrotmongkol, Thanyada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964278/ https://www.ncbi.nlm.nih.gov/pubmed/31956784 http://dx.doi.org/10.1021/acsomega.9b02800 |
Ejemplares similares
-
Pharmacophore-Based
Virtual Screening and Experimental
Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones
por: Sanachai, Kamonpan, et al.
Publicado: (2023) -
Discovery of JAK2/3
Inhibitors from Quinoxalinone-Containing
Compounds
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
por: Longsompurana, Phoomintara, et al.
Publicado: (2023) -
Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
por: Suriya, Utid, et al.
Publicado: (2022)